androstenedione has been researched along with spironolactone in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Bydal, P; Labrie, F; Luu-The, V; Poirier, D | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Siiteri, PK; Walsh, PC | 1 |
| Azarnoff, DL; Hignite, CE; Huffman, DH; Kampmann, JP | 1 |
| Carmina, E; Lobo, RA | 1 |
| Katahira, K; Kohara, K; Kumahara, Y; Mikami, H; Ogihara, T; Ohde, H | 1 |
| Elkind-Hirsch, K; Goldzieher, JW; Young, RL | 1 |
| Lobo, RA; Serafini, P | 1 |
| Biffignandi, P; Massucchetti, C; Molinatti, GM | 1 |
| Coney, P | 1 |
| Sekihara, H | 1 |
| Cumming, DC; Rebar, RW; Yang, JC; Yen, SS | 1 |
| Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
| Lumachi, F; Rondinone, R | 1 |
| Benghuzzi, H; Cason, Z; Phillips, L; Tucci, M | 1 |
| Conway, GS; Dawnay, A; Honour, JW; Tsilchorozidou, T | 1 |
| Pfeifer, M; Prezelj, J; Sebestjen, M; Studen, KB | 1 |
| Belfiore, A; D'Orrico, B; Fava, A; Fruci, B; Guzzi, P; Malaguarnera, R; Mazza, A; Veltri, P | 1 |
| Boran, G; Broderick, D; Conlon, KC; Crowley, RK; Crowther, S; Gibney, J; Maher, V; O'Shea, T; Sherlock, M | 1 |
| Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
| Broux, E; Catteau-Jonard, S; Dewailly, D | 1 |
2 review(s) available for androstenedione and spironolactone
| Article | Year |
|---|---|
Female hirsutism: pathophysiological considerations and therapeutic implications.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Glands; Adrenocorticotropic Hormone; Androgen Antagonists; Androgens; Androstenedione; Biological Transport, Active; Blood Proteins; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Female; Hirsutism; Humans; Kinetics; Ovary; Sex Hormone-Binding Globulin; Skin; Spironolactone | 1984 |
Polycystic ovarian disease: current concepts of pathophysiology and therapy.
Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Glands; Androgen Antagonists; Androstenedione; Animals; Cimetidine; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Spironolactone; Testosterone | 1984 |
5 trial(s) available for androstenedione and spironolactone
| Article | Year |
|---|---|
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Spironolactone; Testosterone | 2003 |
Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome.
Topics: Adult; Aldosterone; Androgen Antagonists; Androgens; Androstenedione; Dehydroepiandrosterone Sulfate; Endothelial Cells; Female; Humans; Lipids; Lipoproteins, LDL; Polycystic Ovary Syndrome; Potassium; Renin; Spironolactone; Testosterone; Triglycerides; Young Adult | 2011 |
In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Female; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Spironolactone; Testosterone; Young Adult | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
17 other study(ies) available for androstenedione and spironolactone
| Article | Year |
|---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
Topics: 17-Hydroxysteroid Dehydrogenases; Cell Line; Cell Proliferation; Enzyme Inhibitors; Humans; Lactones; Male; Prostatic Diseases; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Steroids; Structure-Activity Relationship | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
Topics: Aged; Androgens; Androstenedione; Castration; Dehydroepiandrosterone; Depression, Chemical; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Spironolactone; Testosterone | 1975 |
Gynecomastia induced in normal males by spironolactone.
Topics: Adult; Androstenedione; Estrogens; Gynecomastia; Humans; Luteinizing Hormone; Male; Metabolic Clearance Rate; Progesterone; Spironolactone; Testosterone; Time Factors | 1978 |
Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Drug Combinations; Female; Hirsutism; Humans; Spironolactone; Testosterone | 1991 |
Direct vascular effects of 19-hydroxyandrostenedione.
Topics: Aldosterone; Androstenedione; Animals; Desipramine; Dose-Response Relationship, Drug; Ear; Female; Hemodynamics; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Rabbits; Regional Blood Flow; Spironolactone; Vasoconstriction | 1989 |
The endocrine effects of spironolactone used as an antiandrogen.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Female; Hirsutism; Humans; Middle Aged; Ovariectomy; Spironolactone; Testosterone | 1987 |
The effects of spironolactone on adrenal steroidogenesis in hirsute women.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Cortodoxone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Hydrocortisone; Hydroxyprogesterones; Spironolactone; Steroids; Time Factors | 1985 |
19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
Topics: Aldosterone; Androstenedione; Animals; Blood Pressure; Corticosterone; Desoxycorticosterone; Drug Interactions; Potassium; Rats; Renin; Sodium; Spironolactone | 1983 |
Treatment of hirsutism with spironolactone.
Topics: Amenorrhea; Androgen Antagonists; Androgens; Androstenedione; Cytochrome P-450 Enzyme Inhibitors; Face; Female; Hirsutism; Humans; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Spironolactone; Testosterone | 1982 |
The effect of agonists and antagonists on Hep-2 cells.
Topics: Androstenedione; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Size; Cell Survival; Drug Interactions; Humans; Laryngeal Neoplasms; Mineralocorticoid Receptor Antagonists; Neoplasm Proteins; Spironolactone; Testosterone | 2005 |
Spironolactone interference in the immunoassay of androstenedione.
Topics: Androstenedione; Female; Humans; Immunoassay; Polycystic Ovary Syndrome; Spironolactone | 2010 |
Spironolactone interference in the immunoassay of androstenedione in a patient with a cortisol secreting adrenal adenoma.
Topics: Adrenal Gland Neoplasms; Adult; Androstenedione; Humans; Hydrocortisone; Immunoassay; Male; Spironolactone | 2014 |
[Spironolactone as a relay for cyproterone acetate in hyperandrogenic women].
Topics: Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Female; France; Humans; Hyperandrogenism; Patient Satisfaction; Retrospective Studies; Spironolactone; Testosterone | 2020 |